NanoViricides, Inc. (NNVC) stock
NNVCNYSEPharmaceutical PreparationsFiscal year ends June 30
$1.23−0.12 (-8.89%)
Close on Nov 13, 2026Market cap $31.40MP/E –Yield –
NanoViricides total assets
Total assets on the balance sheet at the end of each period.
NanoViricides's total assets was $9.87M at Jun 30, 2026. For fiscal 2026 it was $9.87M, up 11.9% from the year before. Over ten years it grew -12.3% a year on average. The highest annual figure on record is $44.19M in fiscal 2015.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $9.87M | +11.9% |
| FY2025 | Jun 30, 2025 | $8.82M | -31.2% |
| FY2024 | Jun 30, 2024 | $12.82M | -24.1% |
| FY2023 | Jun 30, 2023 | $16.90M | -28.1% |
| FY2022 | Jun 30, 2022 | $23.49M | -22.4% |
| FY2021 | Jun 30, 2021 | $30.26M | +26.5% |
| FY2020 | Jun 30, 2020 | $23.91M | +77.8% |
| FY2019 | Jun 30, 2019 | $13.45M | -27.5% |
| FY2018 | Jun 30, 2018 | $18.55M | -31.3% |
| FY2017 | Jun 30, 2017 | $27.00M | -26.3% |
| FY2016 | Jun 30, 2016 | $36.63M | -17.1% |
| FY2015 | Jun 30, 2015 | $44.19M | +0.7% |
| FY2014 | Jun 30, 2014 | $43.86M | +167.3% |
| FY2013 | Jun 30, 2013 | $16.41M | +5.0% |
| FY2012 | Jun 30, 2012 | $15.63M | +45.3% |
| FY2011 | Jun 30, 2011 | $10.76M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $9.87M | +11.9% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $10.22M | +1.9% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $12.27M | +6.0% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $8.36M | -28.8% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $8.82M | -31.2% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $10.03M | -12.5% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $11.57M | -13.7% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $11.74M | -23.8% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $12.82M | -24.1% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $11.46M | -38.3% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $13.40M | -34.1% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $15.42M | -30.2% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $16.90M | -28.1% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $18.58M | -26.1% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $20.33M | -24.2% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $22.08M | -24.3% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $23.49M | -22.4% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $25.14M | -23.2% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $26.81M | -4.5% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $29.18M | -8.4% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $30.26M | +26.5% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $32.76M | +98.2% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $28.09M | +141.7% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $31.85M | +170.2% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $23.91M | +77.8% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $16.53M | +7.4% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $11.62M | -22.6% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $11.79M | -32.1% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $13.45M | -27.5% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $15.39M | -31.1% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $15.00M | -36.8% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $17.37M | -31.2% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $18.55M | -31.3% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $22.34M | -21.8% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $23.73M | -24.4% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $25.27M | -26.2% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $27.00M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $28.58M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $31.36M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $34.22M | – |
See a number that looks wrong?